Extract
CytoCore Launches Clinical Trials for the e2 Collector.
Testing Expected to Confirm Performance of New Cervical Cancer Collection Device
CHICAGO -- CytoCore, Inc. (OTCBB:CYCR) today announced that it has begun three "marketing confirmation" trials for the e2 Collector[TM] cervical cell collection device. These trials will compare th...See the full content of this document
Sponsored links
